Univest
Univest
  • Markets

Coral Laboratories (CORALAB) Share Price Rises 14.87% Today: Price Action and Fundamental Analysis

  • November 16, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Coral Laboratories Share Price
Coral Laboratories Ltd. (CORALAB) share price rose to Rs 616 today, up 14.87% from the previous close. Market cap was Rs 191.58 crore.

The Coral Laboratories Share Price stood at Rs 616.00 as of 16 November 2026 at 10:23:08 AM IST, up Rs 79.75 or 14.87% from the previous close of Rs 536.25. Coral Laboratories Ltd. has a market capitalisation of Rs 191.58 crore and belongs to the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Univest data confirms the move itself, though no company-specific trigger has been identified. The Coral Laboratories share price rise is therefore best read through the numbers: the stock opened at Rs 619.00, touched a low of Rs 585.00 and a high of Rs 630.00, and the latest traded price sits inside that range.

Table of Contents

Toggle
  • Coral Laboratories Share Price Today: Price Action Analysis
  • Coral Laboratories Ltd. (CORALAB) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Coral Laboratories
  • About Coral Laboratories
  • Frequently Asked Questions
    • Why is the Coral Laboratories Share Price rising today?
    • What is the Coral Laboratories Share Price today?
    • What is the market cap of Coral Laboratories?
    • What is the P/E ratio of Coral Laboratories?
    • What is the P/B ratio and book value of Coral Laboratories?
    • What are the ROE and ROCE of Coral Laboratories?
    • What is the dividend yield of Coral Laboratories?
    • How does Coral Laboratories compare with its peers?
  • Track Coral Laboratories Share Price on Univest

Coral Laboratories Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 616
Previous Close Rs 536.25
Today's Move Rs 79.75 (+14.87%)
Open Rs 619
High Rs 630
Low Rs 585
Market Capitalisation Rs 191.58 crore
Market Cap Category Micro Cap

Coral Laboratories Ltd. (CORALAB) rose to Rs 616 from the previous close of Rs 536.25, a move of Rs 79.75 or 14.87%. The stock opened at Rs 619, reached a high of Rs 630, recorded a low of Rs 585.

The Coral Laboratories Share Price rose Rs 79.75, or 14.87%, to Rs 616.00 against a previous close of Rs 536.25, as of 16 November 2026 at 10:23:08 AM IST. This is the price move recorded for the stock today, and the notes below place it within the day’s trading range.

The stock opened at Rs 619.00, well above the previous close, so the Coral Laboratories stock price began the day with a gap higher. It then moved between a day low of Rs 585.00 and a day high of Rs 630.00. The latest traded price of Rs 616.00 sits between those two levels, so the Coral Laboratories Share Price has held most of its move so far.

Market capitalisation stands at Rs 191.58 crore at this price. Market cap reflects company size at the current share price and says nothing about business quality, so the next sections test the Coral Laboratories Share Price rise against its financials and its peers. Readers following Coral Laboratories share price live updates can use these levels as reference points as the day progresses.

Coral Laboratories Ltd. (CORALAB) Fundamental Analysis

Metric Value
Market Capitalisation Rs 191.58 crore
P/E Ratio 9.98x
P/B Ratio 0.89x
ROE 7.98%
ROCE 11.14%
EPS Rs 53.76
Book Value Per Share Rs 600.41
Dividend Yield 0.37%

Coral Laboratories Ltd. (CORALAB) fundamental metrics show P/E 9.98x, P/B 0.89x, ROE 7.98%, ROCE 11.14%. Read together, these ratios describe the company’s position rather than a recommendation.

Coral Laboratories Ltd. has a market capitalisation of Rs 191.58 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 9.98x, P/B at 0.89x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.98% and ROCE of 11.14%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 53.76, book value per share of Rs 600.41, dividend yield of 0.37%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 9.98x
Benchmark Median P/E 30.93x
Benchmark Average P/E 52.22x
Benchmark P/E Range 2.6x to 1,177x
Company P/B Ratio 0.89x
Benchmark Median P/B 2.9x
Company ROE 7.98%
Benchmark Median ROE 10.98%
Company ROCE 11.14%
Benchmark Median ROCE 12.63%
Company Market Capitalisation Rs 191.58 crore
Benchmark Median Market Cap Rs 698.04 crore

Coral Laboratories Ltd. (CORALAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Coral Laboratories Ltd. (CORALAB) has a P/E ratio of 9.98x, which is below the benchmark median of 30.93x, a difference of -67.73%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Coral Laboratories Ltd. (CORALAB) has a ROE of 7.98%, which is below the benchmark median of 10.98%, a difference of -27.32%. Coral Laboratories Ltd. (CORALAB) has a ROCE of 11.14%, which is below the benchmark median of 12.63%, a difference of -11.8%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,51,290.91 41.15 5.05 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 3,05,014.11 90.7 16.95 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,333.2 83.49 9.65 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,30,755.56 97.59 21.57 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,18,802.71 28.42 4.27 19.69 21.39

Coral Laboratories Ltd. (CORALAB) has a P/E ratio of 9.98x compared with the displayed peer median of 83.49x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 7.98% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 11.14% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Coral Laboratories Ltd. (CORALAB) has a market capitalisation of Rs 191.58 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Coral Laboratories

Investors tracking Coral Laboratories are looking at a sharp day move together with a low P/E ratio, a P/B ratio below the industry median and returns that trail peer medians. The points below summarise what the verified figures show for the Coral Laboratories Share Price, without any recommendation or forecast.

  • Price action: the stock is trading at Rs 616.00 within a day range of Rs 585.00 to Rs 630.00.
  • Valuation: a P/B ratio of 0.89 against a book value per share of Rs 600.41.
  • Earnings: EPS of Rs 53.76 and a P/E ratio of 9.98, below the industry median of 30.93.
  • Returns: ROE of 7.98% and ROCE of 11.14%, both below the industry medians.
  • Size: market capitalisation of Rs 191.58 crore, below the benchmark median of Rs 698.04 crore.

About Coral Laboratories

Coral Laboratories Ltd. is a listed company trading under the symbol CORALAB. It operates in the Healthcare sector and is classified under the Pharmaceuticals & Drugs industry. At the current price its market capitalisation is Rs 191.58 crore. Within the Univest benchmark group of 205 Pharmaceuticals & Drugs companies, it sits below the median on market capitalisation, ROE and ROCE, which is the backdrop to the Coral Laboratories Share Price today.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is the Coral Laboratories Share Price rising today?

Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. The stock was at Rs 616.00, up 14.87% from the previous close of Rs 536.25, as of 10:23 AM IST.

What is the Coral Laboratories Share Price today?

Ans. The Coral Laboratories Share Price was Rs 616.00 as of 10:23 AM IST on 16 November 2026. The stock opened at Rs 619.00, and the day low is Rs 585.00 while the day high is Rs 630.00.

What is the market cap of Coral Laboratories?

Ans. Coral Laboratories Ltd. has a market capitalisation of Rs 191.58 crore at the current price. Among 205 Pharmaceuticals & Drugs companies, that is below the median of Rs 698.04 crore and the average of Rs 14,540.61 crore.

What is the P/E ratio of Coral Laboratories?

Ans. Coral Laboratories has a P/E ratio of 9.98, with earnings per share of Rs 53.76. The industry benchmark median P/E is 30.93 and the average is 52.22, across 171 benchmark companies that report a P/E.

What is the P/B ratio and book value of Coral Laboratories?

Ans. The P/B ratio is 0.89 and the book value per share is Rs 600.41. The industry median P/B ratio is 2.90 and the average is 3.43, so the P/B ratio sits below both benchmark figures.

What are the ROE and ROCE of Coral Laboratories?

Ans. ROE is 7.98% and ROCE is 11.14%. The industry medians are 10.98% for ROE and 12.63% for ROCE, so both returns are below the medians. ROE measures return on equity, while ROCE measures return on capital employed.

What is the dividend yield of Coral Laboratories?

Ans. The latest Univest figures show a dividend yield of 0.37% for Coral Laboratories. Dividend yield is a historical and current measure, and it does not guarantee or forecast any future payout to shareholders of the company.

How does Coral Laboratories compare with its peers?

Ans. Univest compares it with Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Laurus Labs and Zydus Lifesciences. Its P/E of 9.98 and P/B of 0.89 are below all five, and so is its market cap.

Track Coral Laboratories Share Price on Univest

Use Coral Laboratories Ltd. (CORALAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track the Coral Laboratories Share Price live on Univest, along with fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and wider market insights. Univest also lets readers compare Coral Laboratories with other Pharmaceuticals & Drugs companies, so the Coral Laboratories Share Price rise can be checked against peer data as the day progresses. This is information only and not a recommendation.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply